{"id":"https://openalex.org/W4293199473","doi":"https://doi.org/10.1080/09537325.2022.2115882","title":"The impact of R&D subsidies on firm innovation in different supervision situations: analysis from pharmaceutical companies in China","display_name":"The impact of R&D subsidies on firm innovation in different supervision situations: analysis from pharmaceutical companies in China","publication_year":2022,"publication_date":"2022-08-26","ids":{"openalex":"https://openalex.org/W4293199473","doi":"https://doi.org/10.1080/09537325.2022.2115882"},"language":"en","primary_location":{"id":"doi:10.1080/09537325.2022.2115882","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09537325.2022.2115882","pdf_url":null,"source":{"id":"https://openalex.org/S130699561","display_name":"Technology Analysis and Strategic Management","issn_l":"0953-7325","issn":["0953-7325","1465-3990"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547"],"host_organization_lineage_names":["Taylor & Francis"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Technology Analysis & Strategic Management","raw_type":"journal-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005554363","display_name":"Yuntian Xia","orcid":"https://orcid.org/0000-0002-4198-8938"},"institutions":[{"id":"https://openalex.org/I174385955","display_name":"Hefei Normal University","ror":"https://ror.org/01b64k086","country_code":"CN","type":"education","lineage":["https://openalex.org/I174385955"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yuntian Xia","raw_affiliation_strings":["School of Economics and Management, Hefei Normal University, Hefei, People\u2019s Republic of China","School of Economics and Management, Hefei Normal University, Hefei, People's Republic of China"],"affiliations":[{"raw_affiliation_string":"School of Economics and Management, Hefei Normal University, Hefei, People\u2019s Republic of China","institution_ids":["https://openalex.org/I174385955"]},{"raw_affiliation_string":"School of Economics and Management, Hefei Normal University, Hefei, People's Republic of China","institution_ids":["https://openalex.org/I174385955"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005554363"],"corresponding_institution_ids":["https://openalex.org/I174385955"],"apc_list":null,"apc_paid":null,"fwci":3.008,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.92738208,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"36","issue":"8","first_page":"1792","last_page":"1809"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12722","display_name":"Innovation Policy and R&D","score":0.9991999864578247,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12722","display_name":"Innovation Policy and R&D","score":0.9991999864578247,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9900000095367432,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9126999974250793,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/subsidy","display_name":"Subsidy","score":0.9347929954528809},{"id":"https://openalex.org/keywords/business","display_name":"Business","score":0.6553943753242493},{"id":"https://openalex.org/keywords/government","display_name":"Government (linguistics)","score":0.641915500164032},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.634637713432312},{"id":"https://openalex.org/keywords/productivity","display_name":"Productivity","score":0.6124205589294434},{"id":"https://openalex.org/keywords/audit","display_name":"Audit","score":0.4791114330291748},{"id":"https://openalex.org/keywords/industrial-organization","display_name":"Industrial organization","score":0.47743019461631775},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"Pharmaceutical industry","score":0.41895782947540283},{"id":"https://openalex.org/keywords/public-economics","display_name":"Public economics","score":0.41866815090179443},{"id":"https://openalex.org/keywords/finance","display_name":"Finance","score":0.3702242970466614},{"id":"https://openalex.org/keywords/accounting","display_name":"Accounting","score":0.3390670120716095},{"id":"https://openalex.org/keywords/economics","display_name":"Economics","score":0.312947154045105},{"id":"https://openalex.org/keywords/market-economy","display_name":"Market economy","score":0.24283352494239807},{"id":"https://openalex.org/keywords/economic-growth","display_name":"Economic growth","score":0.08110937476158142}],"concepts":[{"id":"https://openalex.org/C84265765","wikidata":"https://www.wikidata.org/wiki/Q193219","display_name":"Subsidy","level":2,"score":0.9347929954528809},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6553943753242493},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.641915500164032},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.634637713432312},{"id":"https://openalex.org/C204983608","wikidata":"https://www.wikidata.org/wiki/Q2111958","display_name":"Productivity","level":2,"score":0.6124205589294434},{"id":"https://openalex.org/C199521495","wikidata":"https://www.wikidata.org/wiki/Q181487","display_name":"Audit","level":2,"score":0.4791114330291748},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.47743019461631775},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.41895782947540283},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.41866815090179443},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.3702242970466614},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.3390670120716095},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.312947154045105},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.24283352494239807},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.08110937476158142},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/09537325.2022.2115882","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09537325.2022.2115882","pdf_url":null,"source":{"id":"https://openalex.org/S130699561","display_name":"Technology Analysis and Strategic Management","issn_l":"0953-7325","issn":["0953-7325","1465-3990"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547"],"host_organization_lineage_names":["Taylor & Francis"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Technology Analysis & Strategic Management","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure","score":0.6600000262260437}],"awards":[{"id":"https://openalex.org/G561206294","display_name":null,"funder_award_id":"21CGL035","funder_id":"https://openalex.org/F4320326290","funder_display_name":"National Planning Office of Philosophy and Social Science"}],"funders":[{"id":"https://openalex.org/F4320326290","display_name":"National Planning Office of Philosophy and Social Science","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W1892336860","https://openalex.org/W1968338090","https://openalex.org/W1969022755","https://openalex.org/W1969465969","https://openalex.org/W2080157908","https://openalex.org/W2083438286","https://openalex.org/W2173708787","https://openalex.org/W2520372501","https://openalex.org/W2554472901","https://openalex.org/W2576939404","https://openalex.org/W2612812055","https://openalex.org/W2750974904","https://openalex.org/W2776834747","https://openalex.org/W2790590542","https://openalex.org/W2811152878","https://openalex.org/W2903241448","https://openalex.org/W2903992765","https://openalex.org/W2905726141","https://openalex.org/W2915845327","https://openalex.org/W2941441949","https://openalex.org/W2946644518","https://openalex.org/W2955239397","https://openalex.org/W2966085243","https://openalex.org/W2966314200","https://openalex.org/W2969247272","https://openalex.org/W2971403214","https://openalex.org/W2973077205","https://openalex.org/W2981612267","https://openalex.org/W2990418270","https://openalex.org/W2990597316","https://openalex.org/W2996947587","https://openalex.org/W2999038046","https://openalex.org/W3002028048","https://openalex.org/W3015006825","https://openalex.org/W3023688340","https://openalex.org/W3026482844","https://openalex.org/W3036303309","https://openalex.org/W3037200588","https://openalex.org/W3037983570","https://openalex.org/W3040823426","https://openalex.org/W3042935009","https://openalex.org/W3092201405","https://openalex.org/W3096754716","https://openalex.org/W3111886427","https://openalex.org/W3122121511","https://openalex.org/W3122370686","https://openalex.org/W3124097766","https://openalex.org/W3124220939","https://openalex.org/W3146492254","https://openalex.org/W3155107374","https://openalex.org/W3166685353","https://openalex.org/W3193307170","https://openalex.org/W3204376317","https://openalex.org/W3207974371","https://openalex.org/W3210592320","https://openalex.org/W4210489928","https://openalex.org/W4212766871","https://openalex.org/W4229609299"],"related_works":["https://openalex.org/W2276539358","https://openalex.org/W4309036932","https://openalex.org/W3083505014","https://openalex.org/W2099588657","https://openalex.org/W3121609543","https://openalex.org/W1484657374","https://openalex.org/W246549337","https://openalex.org/W3121531574","https://openalex.org/W2050946006","https://openalex.org/W3122591485"],"abstract_inverted_index":{"New":[0],"inventions":[1],"can":[2,85],"increase":[3,86],"productivity,":[4],"accelerate":[5],"the":[6,24,34,47],"creation":[7],"of":[8,26,37,49],"new":[9],"profits,":[10],"and":[11,30,54,66,81,90,113],"provide":[12],"lucrative":[13],"growth":[14],"potential.":[15],"Using":[16],"a":[17,70],"fixed":[18],"effect":[19],"model,":[20],"this":[21],"article":[22],"examines":[23],"influence":[25],"government":[27,63,87],"innovation":[28,64,88,101,117],"subsidies":[29,65,89],"tax":[31,67,91,107],"rebates":[32,68],"on":[33,73],"R&D":[35,76],"production":[36],"pharmaceutical":[38,74,94],"companies":[39],"from":[40,106],"2010":[41],"to":[42,100],"2020.":[43],"It":[44],"also":[45],"assesses":[46],"moderators":[48],"institutional":[50,79],"investors,":[51],"audit":[52],"agencies,":[53],"public":[55,82],"opinion":[56,83],"in":[57],"monitoring.":[58],"The":[59],"research":[60],"finds":[61],"that":[62],"have":[69],"significant":[71],"impact":[72],"enterprises\u2019":[75],"outputs.":[77],"Second,":[78],"shareholding":[80],"supervision":[84],"breaks":[92],"for":[93],"R&D.":[95],"SOEs":[96],"are":[97],"more":[98],"susceptible":[99],"subsidies,":[102],"while":[103],"non-SOEs":[104],"benefit":[105],"rebates.":[108],"This":[109],"study":[110],"assists":[111],"managers":[112],"policymakers":[114],"develop":[115],"effective":[116],"strategies.":[118]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4}],"updated_date":"2026-03-25T14:56:36.534964","created_date":"2025-10-10T00:00:00"}